Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open Label Randomized Controlled Trial of Prophylactic Rectal Indomethacin Versus Combined Pancreatic Duct Stent Placement and Rectal Indomethacin for Prevention of Post-ERCP Pancreatitis

NCT05857514 is registered in ClinicalTrials.gov with Moti Lal Nehru Medical College as lead sponsor.

NCT NCT05857514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05857514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open Label Randomized Controlled Trial of Prophylactic Rectal Indomethacin Versus Combined Pancreatic Duct Stent Placement and Rectal Indomethacin for Prevention of Post-ERCP Pancreatitis
Lead sponsor
Moti Lal Nehru Medical College
Phase
Not applicable
Overall status
Unknown status
Start date
May 10, 2023
Completion date
May 1, 2024
Enrollment
384 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

post-ercp acute pancreatitis